BHC / Bausch + Lomb buys J&J's dry eye relief drops for $107 mln

Bausch (BHC) surpasses third-quarter earnings and sales estimates as most of the business units post growth. more_horizontal

LAVAL, QC / ACCESSWIRE / October 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its third-quarter financial results on Thurs more_horizontal

Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the st more_horizontal

Bausch Health stock fell on Tuesday on the news of its CFO unexpectedly leaving. Wednesday brought a bounce as investors viewed the sell-off as a buyi more_horizontal

Tom Vadaketh is leaving as Bausch's CFO after less than two years with the company. Vadaketh helped oversee financial improvement for Bausch. more_horizontal

Bausch Health Cos. Inc. BHC, -1.76% shares fell nearly 3% premarket on Tuesday after the company announced late Monday that chief financial officer To more_horizontal

There's a reason people are looking for cannabis stocks to buy now. It is increasingly likely that marijuana will be rescheduled from a Schedule I con more_horizontal

Bausch Health finance chief Tom Vadaketh will resign effective Oct. 13 to pursue another opportunity, the Canadian pharmaceutical company said in a re more_horizontal